Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
K Suda, T Mitsudomi - Cells, 2021 - mdpi.com
… to be an important source of cancer cells that eventually acquire irreversible resistance. …
mechanisms of drug tolerance of EGFR-mutated lung cancers employ lung cancer cell lines as …
mechanisms of drug tolerance of EGFR-mutated lung cancers employ lung cancer cell lines as …
Mechanisms of acquired resistance and tolerance to EGFR targeted therapy in non-small cell lung cancer
H Chhouri, D Alexandre, L Grumolato - Cancers, 2023 - mdpi.com
… In this review, we discuss how lung cancer cells become resistant or tolerant to targeted …
of drug-tolerant persister (DTP) cells and the mechanistic basis of drug tolerance in EGFR-…
of drug-tolerant persister (DTP) cells and the mechanistic basis of drug tolerance in EGFR-…
Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse
M Nie, N Chen, H Pang, T Jiang… - The Journal of …, 2022 - Am Soc Clin Investig
… signaling pathways in intestines and gastric cancer (31), we hypothesized that ACh signaling
may regulate the emergence of drug tolerance, potentially by activating WNT signaling. …
may regulate the emergence of drug tolerance, potentially by activating WNT signaling. …
Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer
P Giron, C Eggermont, A Noeparast… - … Journal of Cancer, 2021 - Wiley Online Library
… of EGFR TKI drug tolerance To identify proteins that affect drug tolerance for EGFR TKIs, we
… the screen in parallel using two human lung adenocarcinoma cell lines, PC9 and HCC827. …
… the screen in parallel using two human lung adenocarcinoma cell lines, PC9 and HCC827. …
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
ZF Lim, PC Ma - Journal of hematology & oncology, 2019 - Springer
… drug resistance in lung cancer is shown here as an example. There are two recognized
models of mechanisms of drug … behind minimal residual disease and drug tolerance-resistance …
models of mechanisms of drug … behind minimal residual disease and drug tolerance-resistance …
Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer
S Ohara, K Suda, T Fujino, A Hamada, T Koga… - Lung Cancer, 2021 - Elsevier
… if all EGFR-mutated lung cancers use the same molecular mechanisms to survive as DTCs,
we hypothesized that novel molecular mechanisms of drug tolerance may be identified if we …
we hypothesized that novel molecular mechanisms of drug tolerance may be identified if we …
[HTML][HTML] … drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer
S Nakamichi, M Seike, A Miyanaga, M Chiba, F Zou… - Oncotarget, 2018 - ncbi.nlm.nih.gov
… response in non–small cell lung cancer (NSCLC) patients with … to conquer ALK-positive lung
cancer. We established three … had cancer stem cell-like (CSC) properties, suggesting drug-…
cancer. We established three … had cancer stem cell-like (CSC) properties, suggesting drug-…
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer
S Prekovic, K Schuurman, I Mayayo-Peralta… - Nature …, 2021 - nature.com
… Using a selected array of drugs based on the first screen, we … effectiveness of these drugs
in another lung cancer model, the … drugs clinically approved for the treatment of lung cancer, …
in another lung cancer model, the … drugs clinically approved for the treatment of lung cancer, …
Cell-intrinsic mechanisms of drug tolerance to systemic therapies in cancer
C Leonce, P Saintigny, S Ortiz-Cuaran - Molecular Cancer Research, 2022 - AACR
… Other metabolic pathways are involved in drug tolerance, as demonstrated in lung cancer
… -147b and EGFR delays the emergence of drug tolerance in lung cancer PDX model (134). …
… -147b and EGFR delays the emergence of drug tolerance in lung cancer PDX model (134). …
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
M Ramirez, S Rajaram, RJ Steininger… - Nature …, 2016 - nature.com
… from a single, EGFR-addicted lung cancer cell. We find, using a combination of large-scale …
compelling evidence of transformation to small cell lung cancer, epithelial-to-mesenchymal …
compelling evidence of transformation to small cell lung cancer, epithelial-to-mesenchymal …
相关搜索
- osimertinib tolerance lung cancer
- cell lung cancer
- egfr mutant lung cancer
- resistance mechanisms lung cancer
- innate drug resistance lung cancer cells
- oncogenic drivers in lung cancer
- non-small cell lung cancer drug resistance
- tyrosine kinase inhibitors in lung cancer
- non-small cell lung cancer acquired resistance
- non-small cell lung cancer targeted therapy
- small cell lung cancer cells
- small cell lung cancer drug tolerance
- drug tolerant persister cancer cells
- lung cancers with egfr mutations
- mechanisms of drug tolerance